The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
Incisive Genetics
Vancouver, Canada
A
1-10 Employees
2018
Key takeaway
Incisive Genetics addresses a critical challenge in in vivo gene therapy by utilizing its proprietary Incisive Delivery System™, which offers a safe and effective non-viral method for delivering CRISPR-based gene editing tools directly to target tissues. This innovative approach positions the company at the forefront of advancing genetic medicine.
Highlighted product
Core business
Incisive Genetics
RJH Biosciences
Edmonton, Canada
A
11-50 Employees
2016
Key takeaway
RJH Biosciences specializes in developing innovative transfection reagents and delivery systems that transport various nucleic acids, including siRNA, to human cells. Their focus on effective nucleic acid delivery for preclinical and clinical applications aligns with the growing interest in in vivo gene therapy.
Highlighted product
Product
In Vivo RNA-Fect: RNAi Transfection Reagent - RJH BioSciences
For siRNA administration in animal models Direct administration into specific sites (e.g. intratumorally) or systematic administration
Inagene Diagnostics Inc
Old Toronto, Canada
A
1-10 Employees
2018
Key takeaway
Inagene Diagnostics Inc. focuses on personalized medicine through genetic testing, which can significantly influence treatment responses. Their commitment to privacy and high-quality testing underscores the importance of understanding individual genetic profiles in developing effective therapies.
Highlighted product
Core business
Inagene Diagnostics Inc.
At Inagene, we specialize in providing people personalized insights, based on leading genetic analysis and technology. By ensuring we provide the highest quality testing, we are helping those struggling to feel better, sooner, through personalized medicine.
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Mediphage Bioceuticals
Old Toronto, Canada
A
1-10 Employees
2016
Key takeaway
Mediphage Bioceuticals specializes in gene delivery using its innovative ministring DNA (msDNA) platform, a non-viral gene delivery vector designed to address challenges associated with viral gene therapies. Their focus on developing solutions for genetic and infectious diseases highlights the potential of msDNA technology in advancing gene therapy approaches.
Highlighted product
Product
msDNA Technology — Mediphage Bioceuticals
Cell Therapy Group
Vancouver, Canada
A
1-10 Employees
2008
Key takeaway
The Cell Therapy Group (CTG) specializes in the cell-based regenerative medicine sector, which may encompass in vivo gene therapy approaches. With extensive experience and a focus on companies undergoing significant transitions, CTG is well-positioned to support advancements in this field.
Highlighted product
Core business
Cell Therapy Group
Virogin Biotech
Vancouver, Canada
A
11-50 Employees
2015
Key takeaway
Virogin is focused on developing innovative immuno-oncology therapies, particularly through oncolytic virotherapy using HSV-1 and mRNA-based therapeutics. Their approach aims to enhance anti-tumor immune responses and improve treatment outcomes for patients with solid tumors.
Highlighted product
Product
Technology - Virogin
Technology Oncolytic Virotherapy Oncolytic viruses (OVs) are designed to directly kill tumor cells and induce an anti-tumor immune response. However, the clinical benefit of existing OVs remains limited, due to the inability to improve overall survival for patients. Virogin aims to engineer the viral genome and improve its potency by enhancing replication efficiency and arming […]
Glycovax Pharma
Montreal, Canada
A
1-10 Employees
2015
Key takeaway
Glycovax Pharma is focused on developing innovative therapies, including novel nanoparticles that can target and deliver drugs directly to tumor cells, which is relevant to in vivo gene therapy. Their commitment to exploring new scientific fields and creating personalized strategies aims to significantly improve health outcomes, particularly in cancer and orphan diseases.
Highlighted product
Core business
Nature Glycovax Pharma - Glycovax Pharma
Nature Glycovax Pharma
MINDLAB INTERACTIVE AI INC.
Edmonton, Canada
A
1-10 Employees
2017
Key takeaway
MindBytes is involved in advancing healthcare through the development of evidence-based digital health tools and has a team dedicated to exploring scientific research, including developments in gene therapy for hemophilia. Their focus on collaborative partnerships and clinically validated frameworks positions them as a resource for understanding innovative treatments.
Highlighted product
Service
PREFER PAVING: GENE THERAPY IN HAEMOPHILIA – MindBytes
AGADA Biosciences
Halifax, Canada
A
11-50 Employees
2013
Key takeaway
AGADA Biosciences is focused on in vivo functional outcomes, which highlights its relevance to in vivo gene therapy.
Highlighted product
Service
In Vivo Functional Outcomes – AGADA Biosciences
BlueRock Therapeutics
Old Toronto, Canada
A
101-250 Employees
2016
Key takeaway
BlueRock Therapeutics is focused on developing innovative cell and gene therapies, particularly through its proprietary technology and advanced gene editing, which may have implications for in vivo gene therapy approaches. Their commitment to regenerative medicine and creating new cellular therapies aims to transform disease treatment and improve patient outcomes.
Highlighted product
Product
Platform - BlueRock Therapeutics LP
BlueRock pioneers cell and gene therapies through its platform, utilizing proprietary technology and advanced gene editing.
Technologies which have been searched by others and may be interesting for you:
The In Vivo Gene Therapy industry in Canada presents a dynamic landscape characterized by several key considerations. Regulatory compliance is paramount, as Health Canada oversees the approval of gene therapy products, ensuring they meet stringent safety and efficacy standards. The evolving regulatory framework necessitates staying updated on guidelines, which can impact the speed of product development and market entry. Additionally, the competitive landscape features a mix of established biotech firms and emerging startups, each striving for innovation in gene delivery methods and therapeutic applications. Challenges include addressing manufacturing complexities, ensuring scalable production processes, and overcoming potential patient safety concerns. Opportunities abound in the form of growing investments in research and development, bolstered by government funding and partnerships with academic institutions. The global market relevance of In Vivo Gene Therapy is significant, as advancements in technology and increasing patient demand for personalized medicine create avenues for expansion. Environmental considerations, such as the management of biological waste and the long-term impact of gene therapies, are also critical factors for companies to address. Understanding these aspects is essential for anyone interested in navigating the In Vivo Gene Therapy sector in Canada.
Some interesting numbers and facts about your company results for In Vivo Gene Therapy
| Country with most fitting companies | Canada |
| Amount of fitting manufacturers | 208 |
| Amount of suitable service providers | 135 |
| Average amount of employees | 1-10 |
| Oldest suiting company | 2008 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for In Vivo Gene Therapy
What are related technologies to In Vivo Gene Therapy?
Based on our calculations related technologies to In Vivo Gene Therapy are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on In Vivo Gene Therapy?
The most represented industries which are working in In Vivo Gene Therapy are Biotechnology, Other, Healthcare, Medical, Pharmaceuticals
How does ensun find these In Vivo Gene Therapy Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
